- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT04618120
Virtual Reality-based Exercise Training in Radiotherapy Period After Breast Cancer Surgery
Comparison of Exercise Practices With Virtual Reality-based Exercise Training in Radiotherapy Period After Breast Cancer Surgery
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
Emek
-
Ankara, Emek, Turkey, 06490
- Gazi University Faculty of Health Sciences
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- Being over 18 years old
- Being literate
- Having a diagnosis of unilateral breast cancer
- Having undergone surgery for breast cancer
- Radiotherapy will be applied for breast cancer treatment.
Exclusion Criteria:
- Metastasis
- Have an active infection
- Having a cardiac or neurological disease that would prevent participation in the study
- Having uncontrolled hypertension
- Having an orthopedic disorder that prevents exercise
- Having sensory or cognitive impairments that interfere with communication
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: Virtual Reality-based Exercise Group
Virtual reality-based exercises, breathing exercises and patient education on general considerations. Virtual reality-based exercises were done using the "Microsoft Xbox 360 Kinect" system. Among the 'Kinect Sports' games, especially tennis, table tennis, boxing and bowling games including upper extremity movements were selected. These games require all-directional and repetitive motion of the shoulder and elbow joint. Patients played the games using the operated / affected side arms. Between games, the patient was rested in a chair. In the meantime, deep breathing exercises were done. The patients participated in virtual reality-based exercises 3 days a week (15-18 sessions in total) during the radiotherapy treatment continued (5-6 weeks). Each exercise session was set to last 30-40 minutes in total. |
Virtual reality-based exercises with "Microsoft Xbox 360 Kinect" and breathing exercises. Patient education |
Experimental: Exercise Group
Stretching exercises, range of motion exercises, posture exercises, breathing exercises and patient education on general considerations. 11 different exercises consisting of shoulder range of motion in all directions, stretching exercises, posture exercises and breathing exercises were performed in the presence of a physiotherapist.The patients participated in this exercise program 3 days a week (15-18 sessions in total) during the radiotherapy treatment continued (5-6 weeks). One session of the exercises was completed in an average of 30-40 minutes. The same exercises were repeated in each session. |
Shoulder range of motion, stretching, posture and breathing exercises.
Patient education
|
No Intervention: Control Group
Only patient education on general considerations.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Change in the shoulder range of motion
Time Frame: Baseline and after the exercise training (5-6 weeks)
|
Universal Goniometer
|
Baseline and after the exercise training (5-6 weeks)
|
Change in the grip strength assessed by hydraulic hand dynamometer
Time Frame: Baseline and after the exercise training (5-6 weeks)
|
Jamar Hydraulic Hand Dynamometer
|
Baseline and after the exercise training (5-6 weeks)
|
Change in the shoulder proprioception assessed by isokinetic dynamometer
Time Frame: Baseline and after the exercise training (5-6 weeks)
|
Cybex 770 Norm isokinetic dynamometer (Lumex Inc.
NY,USA)
|
Baseline and after the exercise training (5-6 weeks)
|
Change in circumference of upper extremities
Time Frame: Baseline and after the exercise training (5-6 weeks)
|
Lymphedema circumference measurement
|
Baseline and after the exercise training (5-6 weeks)
|
Change in the functionality of upper extremities assessed by the Disability of Arm, Shoulder and Hand Questionnaire
Time Frame: Baseline and after the exercise training (5-6 weeks)
|
The Turkish version of the Disability of Arm, Shoulder and Hand Questionnaire is used to evaluate functional status of upper extremities.
The questionnaire consists of 30 questions.
A score between 0-100 is obtained from the questionnaire.
0 point means "no disability", 100 point means "maximum level of disability".
|
Baseline and after the exercise training (5-6 weeks)
|
Change in kinesiophobia assessed by theTampa Kinesiophobia Scale
Time Frame: Baseline and after the exercise training (5-6 weeks)
|
The Turkish version of theTampa Kinesiophobia Scale was used to determine the level of kinesiophobia.
4-point Likert scoring (1 = Strongly disagree, 4 = Strongly agree) is used in the scale.
After reversing items 4, 8, 12 and 16, a total score is calculated.
A score between 17-68 is obtained from the scale.
The higher scores indicate higher kinesiophobia level.
|
Baseline and after the exercise training (5-6 weeks)
|
Change in anxiety and depression level assessed by the Hospital Anxiety and Depression Scale
Time Frame: Baseline and after the exercise training (5-6 weeks)
|
The Turkish version of the Hospital Anxiety and Depression Scale was used to determine the anxiety and depression level.
The scale consists of 14 questions in total.
7 of the questions measure depression, 7 measure anxiety.
A total score between 0-42 is obtained from the sum of the anxiety and depression scores.
The higher scores indivate higher depression and /or anxiety.
|
Baseline and after the exercise training (5-6 weeks)
|
Change in fatigue assessed by Piper Fatigue Scale
Time Frame: Baseline and after the exercise training (5-6 weeks)
|
The Turkish version of Piper Fatigue Scale was used to determine the level of fatigue. The scale consists of 22 items (0-10 points) and 4 subscales: behavioral/severitiy (6 items), affective meaning (5 items), sensory (5 items) and cognitive/mood (6 items). Each subscale is scored individually and then aggregated together for an overall score. Higher scores indicate more fatigue. As a result of the average score; 0 points are interpreted as no fatigue, 1-3 points mild fatigue, 4-6 points moderate fatigue, 7-10 points severe fatigue. There are also 5 more questions in the scale that are not used in the subscale or total score calculation. These open-ended questions are about the duration of perceived fatigue, its causes, methods to alleviate fatigue and associated symptoms. They provide qualitative data. |
Baseline and after the exercise training (5-6 weeks)
|
Change in quality of life assessed by the European Organization for Research and Treatment of Cancer Quality of Life Questionnaire (EORTC QLQ-C30)
Time Frame: Baseline and after the exercise training (5-6 weeks)
|
The Turkish version of the European Organization for Research and Treatment of Cancer Quality of Life Questionnaire (EORTC QLQ-C30) was used to evaluate quality of life level.
It contains five functioning scales (physical, social, role, cognitive, and emotional functioning), eight symptom scales (fatigue, nausea/vomiting, pain, dyspnea, sleep disturbances, appetite loss, constipation, and diarrhea), financial impact, and overall quality of life.
All scale scores are converted to range from 0 to 100.
higher scores indicate better functioning for the functioning scales and overall quality of life; higher scores indicate higher symptom burden for the symptom scales.
|
Baseline and after the exercise training (5-6 weeks)
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Patient Satisfaction
Time Frame: Patient satisfaction was evaluated at the end of the 5-6 week exercise training.
|
The motivation of the exercises, the state of enjoying the exercise, believing that the exercise is beneficial, and the patient's willingness to continue the exercise were evaluated with 4 questions that they could answer with Likert-type answers.
|
Patient satisfaction was evaluated at the end of the 5-6 week exercise training.
|
Collaborators and Investigators
Sponsor
Investigators
- Principal Investigator: İlknur Onurlu, PhD, Gazi University Faculty of Medicine, Department of Physical Medicine and Rehabilitation
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- 2407471012
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Breast Cancer
-
Rutgers, The State University of New JerseyNational Cancer Institute (NCI); Rutgers Cancer Institute of New JerseyActive, not recruitingStage IIIA Breast Cancer | Stage IIIB Breast Cancer | Triple-negative Breast Cancer | Stage IIA Breast Cancer | Stage IIB Breast Cancer | Stage IIIC Breast Cancer | Estrogen Receptor-negative Breast Cancer | Progesterone Receptor-negative Breast Cancer | HER2-negative Breast CancerUnited States
-
University of Southern CaliforniaNational Cancer Institute (NCI)TerminatedMale Breast Cancer | Stage IV Breast Cancer | Stage II Breast Cancer | Stage IIIA Breast Cancer | Stage IIIB Breast Cancer | Stage IA Breast Cancer | Stage IB Breast Cancer | Stage IIIC Breast Cancer | Recurrent Breast CancerUnited States
-
University of WashingtonTerminatedBreast Cancer | Breast Cancer Stage I | Breast Cancer Stage II | Breast Cancer Stage III | Breast Cancer Stage IIB | Breast Cancer Stage IIA | Breast Cancer Stage IIIA | Breast Cancer Stage IIIB | Breast Cancer Stage IIIcUnited States
-
CelgeneCompletedBreast Cancer | Metastatic Breast Cancer | Stage IV Breast Cancer | Triple-negative Breast Cancer | Recurrent Breast Cancer | Breast Tumor | Cancer of the Breast | Triple-negative Metastatic Breast Cancer | Estrogen Receptor- Negative Breast Cancer | HER2- Negative Breast Cancer | Progesterone Receptor- Negative...United States, United Kingdom, Italy, Germany, Spain, Canada, Portugal, Australia, Austria, Greece, Brazil, France
-
University of Southern CaliforniaNational Cancer Institute (NCI)TerminatedHER2-positive Breast Cancer | Stage IV Breast Cancer | Stage II Breast Cancer | Stage IIIA Breast Cancer | Stage IIIB Breast Cancer | Stage IA Breast Cancer | Stage IB Breast Cancer | Stage IIIC Breast Cancer | Recurrent Breast CancerUnited States
-
University of WashingtonNational Cancer Institute (NCI)CompletedHER2-positive Breast Cancer | Stage II Breast Cancer | Stage IIIA Breast Cancer | Stage IA Breast Cancer | Stage IB Breast Cancer | Estrogen Receptor-negative Breast Cancer | Estrogen Receptor-positive Breast Cancer | Progesterone Receptor-negative Breast Cancer | Progesterone Receptor-positive Breast...United States
-
University of WashingtonNational Cancer Institute (NCI)CompletedHER2-positive Breast Cancer | Male Breast Cancer | Stage IV Breast Cancer | Stage II Breast Cancer | Stage IIIA Breast Cancer | Stage IIIB Breast Cancer | Stage IIIC Breast Cancer | Recurrent Breast CancerUnited States
-
Sidney Kimmel Cancer Center at Thomas Jefferson...Susan G. Komen Breast Cancer FoundationCompletedStage II Breast Cancer | Stage IIIA Breast Cancer | Stage IIIB Breast Cancer | Triple-negative Breast Cancer | Stage IIIC Breast Cancer | Estrogen Receptor-negative Breast Cancer | Progesterone Receptor-negative Breast Cancer | HER2-negative Breast CancerUnited States
-
Northwestern UniversityEisai Inc.UnknownMale Breast Cancer | Stage II Breast Cancer | Stage IIIA Breast Cancer | Stage IIIB Breast Cancer | Triple-negative Breast Cancer | Stage IA Breast Cancer | Stage IB Breast Cancer | Stage IIIC Breast Cancer | Estrogen Receptor-negative Breast Cancer | Progesterone Receptor-negative Breast Cancer | HER2-negative...United States
-
Ohio State University Comprehensive Cancer CenterCompletedStage II Breast Cancer | Stage IIIA Breast Cancer | Stage IIIB Breast Cancer | Stage IIA Breast Cancer | Stage IIB Breast Cancer | Stage IIIC Breast Cancer | Stage III Breast CancerUnited States
Clinical Trials on Virtual reality-based exercise
-
Craig HospitalCompletedTraumatic Brain InjuryUnited States
-
University of ExeterCairo UniversityNot yet recruiting
-
Baylor College of MedicineNational Institutes of Health (NIH)CompletedCancer | Chemotherapy Induced Peripheral NeuropathyUnited States
-
Maged BashaCairo University; Prince Sattam Bin Abdulaziz UniversityCompleted
-
The University of Texas Health Science Center at...National Center for Advancing Translational Sciences (NCATS)RecruitingParkinson DiseaseUnited States
-
Istanbul University - Cerrahpasa (IUC)RecruitingJuvenile Idiopathic ArthritisTurkey
-
University of VictoriaMeta Platforms, Inc.RecruitingPhysical Activity | Mental Health | Mood | Well-Being, PsychologicalCanada
-
Kessler FoundationCompletedTraumatic Brain InjuryUnited States
-
Istanbul University - Cerrahpasa (IUC)RecruitingScoliosis | Adolescent Idiopathic Scoliosis | Scoliosis; Adolescence | Scoliosis Lumbar RegionTurkey
-
Mental Health Services in the Capital Region, DenmarkRigshospitalet, Denmark; University of Copenhagen; TrygFonden, DenmarkRecruitingDepression | Psychotic Disorders | Schizophrenia | Cognitive Impairment | Bipolar Disorder | Schizotypal DisorderDenmark